This is a non-core endpoint: only basic statistics are computed.
Small cell lung cancer
C3_SCLC
non-small cell lung carcinoma: A group of at least three distinct histological types of lung cancer, including non-small cell squamous cell carcinoma, adenocarcinoma, and large cell carcinoma. Non-small cell lung carcinomas have a poor response to conventional chemotherapy.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditions
|
1005 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
1005 |
4. Check minimum number of eventsNone |
1005 |
5. Include endpoints |
1005 |
6. Filter based on genotype QC (FinnGen only) |
970 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE
- Control conditions
- not HLP_C3_SCLC
Extra metadata
- Level in the ICD hierarchy
- C
- First used in FinnGen datafreeze
- DF8
Similar endpoints
↥List of similar endpoints to
Small cell lung cancer
based on the number of shared cases.
Similar with more cases:
- Small cell lung cancer, including Hilmo
- Small cell lung cancer, helper endpoint
- Malignant neoplasm of bronchus and lung
- Malignant neoplasm of respiratory system and intrathoracic organs
- Malignant neoplasm of bronchus and lung, including Hilmo
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 970 | 226 | 744 |
| Unadjusted period prevalence (%) | 0.28 | 0.08 | 0.34 |
| Median age at first event (years) | 70.95 | 68.89 | 71.57 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 1005
- Matched controls
- 10050
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
C34.1
ICD-10 Finland
Malignant neoplasm: Upper lobe, bronchus or lung
+∞
322.8
292
*
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
12.2
315.4
401
517
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
59.2
307.7
240
53
C34.16
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary microcellular carcinoma
+∞
307.7
305
*
A04AA01
ATC
ondansetron; systemic, rectal
55.4
307.7
238
56
H02AB02
ATC
dexamethasone; systemic
185.8
307.7
422
39
UGC12
NOMESCO Finland
Flexible bronchoscopy
16.7
307.7
398
380
130
Kela drug reimbursment
Malignant tumour
+∞
307.7
560
*
A03FA01
ATC
metoclopramide; systemic, rectal
19.4
307.7
527
540
8041/3-C34.9
ICD-O-3
Small cell carcinoma, NOS, of lung, NOS
+∞
307.7
635
*
L01CB01
ATC
etoposide; systemic
+∞
299.4
272
*
Z51.5
ICD-10 Finland
Palliative care
16.8
280.8
260
204
C34.86
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary microcellular carcinoma
+∞
240.6
221
*
C34.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bronchus and lung
+∞
221.2
204
*
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
1275.6
217.0
204
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2732.7
216.7
202
*
C34.36
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung microcellular carcinoma
+∞
185.3
172
*
8041/3-C34.1
ICD-O-3
Small cell carcinoma, NOS, of upper lobe, lung
+∞
179.7
167
*
C34.3
ICD-10 Finland
Malignant neoplasm: Lower lobe, bronchus or lung
+∞
167.5
156
*
N02AA05
ATC
oxycodone; systemic
6.1
156.9
364
852
GD5BD
NOMESCO Finland
Thorax and upper abdomen combined extensive CT examination of
28.5
153.3
105
41
WF004
NOMESCO Finland
Palliative radiotherapy
+∞
153.1
143
*
XX3DW
NOMESCO Finland
Time consuming IT work
11.3
145.3
164
170
C34.9
ICD-10 Finland
Malignant neoplasm: Bronchus or lung, unspecified
+∞
143.2
134
*
C34.90
ICD-10 Finland
Malignant tumor in unspecified location in bronchus and lung without histology
+∞
130.1
122
*
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
359.3
126.5
125
*
A04AA02
ATC
granisetron; systemic, transdermal
1346.8
124.8
119
*
8041/3-C34.3
ICD-O-3
Small cell carcinoma, NOS, of lower lobe, lung
+∞
118.1
111
*
JN4BD
NOMESCO Finland
Extensive body CT
9.1
116.2
154
196
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
114.8
108
*
C34.96
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary microcellular carcinoma
+∞
111.6
105
*
WF002
NOMESCO Finland
Radical radiotherapy
246.7
109.0
110
5
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
107.2
101
*
C34.06
ICD-10 Finland
Malignant tumor of the main bronchial microcellular carcinoma
+∞
102.9
97
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
10.0
92.7
111
123
C34.0
ICD-10 Finland
Malignant neoplasm: Main bronchus
+∞
87.8
83
*
L03AA13
ATC
pegfilgrastim; parenteral
314.6
86.1
86
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
902.0
85.9
83
*
C34.99
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary other or unspecified histology
+∞
84.6
80
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
83.5
79
*
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
854.7
81.7
79
*
AA1BD
NOMESCO Finland
Extensive CT of head and brain
14.6
78.3
72
53
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
78.2
74
*
JN4AD
NOMESCO Finland
Body CT examination
6.3
73.5
133
236
A04AA55
ATC
palonosetron, combinations; systemic
+∞
71.7
68
*
C34.80
ICD-10 Finland
Malignant overall tumor of bronchus and lung without histology
+∞
63.2
60
*
C34.19
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung other or unspecified histology
+∞
61.1
58
*
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
18.2
57.9
47
27
ZX090
NOMESCO Finland
Other technic of radiotherapy
153.7
55.5
58
*
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
6.0
53.6
101
185
8041/3-C34.0
ICD-O-3
Small cell carcinoma, NOS, of main bronchus
+∞
53.6
51
*
GD5AD
NOMESCO Finland
Thorax and upper abdomen combined CT examination of
18.7
53.6
43
24
C34.00
ICD-10 Finland
Malignant tumor of the main bronchus without histology
+∞
52.6
50
*
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
+∞
50.4
48
*
C34.30
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung without histology
+∞
50.4
48
*
ZX070
NOMESCO Finland
Intensity modified radiotherapy
512.2
49.8
49
*
XGX32
NOMESCO Finland
Bronchoscopic ultrasonography
83.1
49.4
55
7
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
257.3
48.5
49
*
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
48.3
46
*
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
134.2
48.2
51
*
R84
ICPC
Malignant neoplasm bronchus/lung
490.1
47.7
47
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
91.4
47.3
52
6
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
17.9
46.5
38
22
C34.2
ICD-10 Finland
Malignant neoplasm: Middle lobe, bronchus or lung
+∞
46.2
44
*
C34.26
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung microcellular carcinoma
+∞
46.2
44
*
A98
ICPC
Health maint/preventive medicine
0.4
45.3
430
6586
TGD00
NOMESCO Finland
Needle biopsy of lung
125.9
45.2
48
*
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
45.1
43
*
L03AA02
ATC
filgrastim; parenteral
160.5
44.2
46
*
YG1CD
NOMESCO Finland
Very extensive CT examination of thorax for dose design of radiotherapy
+∞
44.1
42
*
ZX080
NOMESCO Finland
Image guided radiotherapy
+∞
43.0
41
*
J44.8
ICD-10 Finland
Other specified chronic obstructive pulmonary disease
2.7
41.7
285
1268
C61
ICD-10 Finland
Malignant neoplasm of prostate
218.9
41.2
42
*
WZC00
NOMESCO Finland
Treatment plan or consultation
2.8
40.8
273
1200
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
112.2
40.0
43
*
N02AA01
ATC
morphine; systemic, rectal
9.0
39.0
49
57
8041/3-C34.2
ICD-O-3
Small cell carcinoma, NOS, of middle lobe, lung
+∞
38.8
37
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
38.8
37
*
WW500
NOMESCO Finland
Blood transfusion
7.4
37.6
56
80
GD1CT
NOMESCO Finland
Biopsy of the lung with CT guidance
44.8
35.2
43
10
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
+∞
33.5
32
*
1623B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,CA MICROCELLURE]
+∞
33.5
32
*
UGC18
NOMESCO Finland
Flexible bronchoscopy with biopsy of lung
76.9
33.1
37
5
JN4CD
NOMESCO Finland
Very extensive body CT
9.8
32.6
38
40
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
+∞
32.5
31
*
GD1AD
NOMESCO Finland
Thorax CT examination
4.5
32.2
81
190
L01XX17
ATC
[U] topotecan
+∞
31.4
30
*
C34.39
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other or unspecified histology
+∞
30.4
29
*
A04AD12
ATC
aprepitant; systemic
+∞
30.4
29
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
+∞
27.2
26
*
N06DX01
ATC
memantine; oral
0.1
26.7
7
852
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
26.2
25
*
N07BA03
ATC
varenicline; oral
5.4
25.7
52
101
116
Kela drug reimbursment
Prostate cancer
+∞
25.1
24
*
C34.89
ICD-10 Finland
Malignant overall tumor of the bronchus and lung other or unspecified histology
+∞
25.1
24
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
256.2
24.8
25
*
J90
ICD-10 Finland
Pleural effusion, not elsewhere classified
4.0
24.3
72
191
R03AL06
ATC
olodaterol and tiotropium bromide; inhalant
5.8
24.1
45
81
WF003
NOMESCO Finland
Adjuvant radiotherapy
+∞
24.1
23
*
L01CE01
ATC
topotecan; systemic
+∞
23.0
22
*
C34.11
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma
+∞
23.0
22
*
1625B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Lower lobe, bronchus or lung[NEOPL MAL LOBI INFERIORIS PULMONIS,CA MICROCELLURE]
+∞
23.0
22
*
C79.31
ICD-10 Finland
Secondary malignant tumor of the cerebellum
+∞
23.0
22
*
A06AH03
ATC
naloxegol; oral
18.9
21.8
33
18
GAA10
NOMESCO Finland
Intercostal insertion of pleural drainage tube
6.1
21.8
38
64
Z51.0
ICD-10 Finland
Radiotherapy session
224.7
21.7
22
*
R03BB04
ATC
tiotropium bromide; inhalant
2.3
21.4
192
939
H02AB06
ATC
prednisolone; systemic
1.9
21.4
477
3246
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
20.9
20
*
GD1AT
NOMESCO Finland
Biopsy of the lung with ultrasound guidance
112.4
20.6
22
*
WW200, ,
SPAT
0.2
20.4
21
1199
N40
ICD-10 Finland
Hyperplasia of prostate
0.4
20.3
124
2592
C79.3
ICD-10 Finland
Secondary malignant neoplasm of brain and cerebral meninges
+∞
19.9
19
*
TGE00
NOMESCO Finland
Needle biopsy of mediastinum
56.1
19.0
22
*
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
+∞
18.8
18
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
18.8
18
*
C34.09
ICD-10 Finland
Malignant tumor of the main bronchus other or unspecified histology
+∞
18.8
18
*
F17.29
ICD-10 Finland
Addiction caused by tobacco UNS
7.2
18.7
28
40
I10
ICD-10 Finland
Essential (primary) hypertension
0.5
18.7
372
5224
R03AK03
ATC
[U] fenoterol and ipratropium bromide
2.3
18.3
148
690
N06DA02
ATC
donepezil; oral
0.1
17.9
7
633
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
17.8
17
*
ZX120
NOMESCO Finland
Intravenous
2.8
17.4
92
349
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
0.1
17.3
15
977
SAA02
NOMESCO Finland
Basic examination of mouth
0.5
17.0
189
3213
NK6AN
NOMESCO Finland
Total body bone isotope imaging
64.5
16.8
19
*
D38.6
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Respiratory organ, unspecified
35.7
16.7
21
6
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
16.7
16
*
WZC30
NOMESCO Finland
Teaching
2.5
16.7
114
492
A79
ICPC
Malignancy NOS
91.6
16.6
18
*
SFA20
NOMESCO Finland
Two-surface restoration
0.5
16.3
157
2812
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
48.3
16.1
19
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
+∞
15.7
15
*
GD5CD
NOMESCO Finland
Thorax and upper abdomen combined very extensive CT examination of
22.5
15.6
22
10
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
15.3
387
2660
P20
ICPC
Memory disturbance
0.3
15.2
36
1219
G04CA02
ATC
tamsulosin; oral
0.5
14.8
165
2833
C34.20
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung without histology
+∞
14.6
14
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
14.6
14
*
115
Kela drug reimbursment
Breast cancer
+∞
14.6
14
*
1240
FHL
Bronchoscopy
4.8
14.5
33
71
SAA01
NOMESCO Finland
Simple examination of mouth
0.6
14.4
248
3738
E87.1
ICD-10 Finland
Hypo-osmolality and hyponatraemia
2.9
13.9
67
242
H25.1
ICD-10 Finland
Senile nuclear cataract
0.5
13.8
154
2657
C10AA05
ATC
atorvastatin; oral
0.5
13.7
207
3256
Z72.0
ICD-10 Finland
Tobacco use
5.0
13.6
29
59
C34.15
ICD-10 Finland
Malignant tumor of the anterior, bronchial or lung other non-microcellular carcinoma
+∞
13.6
13
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
13.6
13
*
R59.0
ICD-10 Finland
Localized enlarged lymph nodes
5.3
13.5
27
52
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
0.5
13.4
199
3152
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
2.9
13.1
64
233
D38.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Mediastinum
50.7
12.9
15
*
SFA10
NOMESCO Finland
One-surface restoration
0.5
12.8
161
2689
L02AE02
ATC
leuprorelin; implant, parenteral
70.8
12.6
14
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
12.5
12
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
12.5
12
*
1628B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Other parts of bronchus or lung[NEOPL MAL PULMONIS LOCO MULTIPLICI,CA MICROCELLURE]
+∞
12.5
12
*
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
0.5
12.5
107
2032
ZX050
NOMESCO Finland
Stereotactic radiotherapy
131.6
12.5
13
*
PJA12
NOMESCO Finland
Sentinel node biopsy
131.6
12.5
13
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
21.6
12.0
17
8
I87.1
ICD-10 Finland
Compression of vein
47.2
11.9
14
*
M25.5
ICD-10 Finland
Pain in joint
0.4
11.9
60
1405
J01MA12
ATC
levofloxacin; systemic
1.8
11.9
199
1201
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
0.5
11.8
144
2439
M79.6
ICD-10 Finland
Pain in limb
0.5
11.7
127
2236
EB1AA
NOMESCO Finland
Intraoral radiographic dental examination
0.5
11.7
170
2736
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
0.4
11.7
71
1541
G30.1
ICD-10 Finland
Alzheimer disease with late onset
0.2
11.6
12
697
J01MA14
ATC
moxifloxacin; systemic
2.2
11.6
97
456
GEA00
NOMESCO Finland
Mediastinoscopy
23.2
11.6
16
7
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
5.1
11.5
24
48
C34.35
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung other non-microcellular carcinoma
+∞
11.5
11
*
A04AA03
ATC
tropisetron; systemic
+∞
11.5
11
*
L02BB03
ATC
bicalutamide; oral
+∞
11.5
11
*
C34.29
ICD-10 Finland
Malignant tumor of the middle lobe, bronchus or lung other or unspecified histology
+∞
11.5
11
*
M01AH05
ATC
etoricoxib; oral
0.6
11.4
216
3233
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic
0.6
11.1
181
2826
SFA30
NOMESCO Finland
Three-surface restoration
0.5
11.1
115
2057
EB1VA, ,
NOMESCO Finland
0.1
10.8
6
423
N02BE01
ATC
paracetamol; systemic, rectal
0.6
10.8
541
6491
K02.1
ICD-10 Finland
Caries of dentine
0.6
10.7
184
2839
R85
ICPC
Malignant neopl respiratory other
60.7
10.6
12
*
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
3.4
10.5
38
116
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
111.1
10.4
11
*
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
+∞
10.4
10
*
C50.41
ICD-10 Finland
Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor
+∞
10.4
10
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
+∞
10.4
10
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
+∞
10.4
10
*
GEA20
NOMESCO Finland
Mediastinoscopy with excision of lesion
+∞
10.4
10
*
SDA03
NOMESCO Finland
Periodontal treatment
0.5
10.4
84
1643
C10AA07
ATC
rosuvastatin; oral
0.5
10.4
104
1888
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.0
10.4
46
159
HA1AE
NOMESCO Finland
Ultrasound examination of mammary glands
5.2
10.3
21
41
N03AX14
ATC
levetiracetam; systemic
3.5
10.1
34
99
290
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
10.0
56
1264
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
10.0
399
2993
J01DB01
ATC
cefalexin; oral
0.7
10.0
455
5625
Z01.2
ICD-10 Finland
Dental examination
0.5
10.0
109
1929
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
0.5
9.9
74
1492
SDA02
NOMESCO Finland
Periodontal treatment, brief
0.5
9.9
76
1515
J38.0
ICD-10 Finland
Paralysis of vocal cords and larynx
4.8
9.8
22
47
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
9.7
73
328
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
3.9
9.7
28
73
G04CB01
ATC
finasteride; oral
0.5
9.7
75
1493
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
13.5
9.7
16
12
J44.9
ICD-10 Finland
Chronic obstructive pulmonary disease, unspecified
2.0
9.7
104
540
Z02.4
ICD-10 Finland
Examination for driving licence
0.5
9.6
126
2113
I69.3
ICD-10 Finland
Sequelae of cerebral infarction
0.3
9.5
31
897
TGD04
NOMESCO Finland
Needle biopsy of the lungs in bronchoscopy
15.2
9.5
15
10
G04CA52
ATC
tamsulosin and dutasteride; systemic
0.4
9.5
39
1009
R04.2
ICD-10 Finland
Haemoptysis
2.6
9.5
54
213
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.6
9.5
191
2847
G04CB02
ATC
dutasteride; oral
0.3
9.4
23
775
M05BX04
ATC
denosumab; parenteral
2.9
9.4
43
151
8500/3-C50.9
ICD-O-3
Infiltrating duct carcinoma, NOS, of breast, NOS
101.0
9.4
10
*
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
101.0
9.4
10
*
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
+∞
9.4
9
*
C34
ICD-10 Finland
Malignant neoplasm of bronchus and lung
+∞
9.4
9
*
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
9.4
9
*
C34.81
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary epidermoid carcinoma
+∞
9.4
9
*
1622B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Main bronchus[NEOPL MAL BRONCH PRINCIP,CA MICROCELLURE]
+∞
9.4
9
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
9.4
9
*
C80.90
ICD-10 Finland
Malignant tumor without specified localization without histology
+∞
9.4
9
*
C34.91
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary epidermoid carcinoma
+∞
9.4
9
*
C34.82
ICD-10 Finland
Malignant overall tumor of bronchial and pulmonary adenocarcinoma
+∞
9.4
9
*
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
+∞
9.4
9
*
L08
ICPC
Shoulder symptom/complaint
0.4
9.3
43
1054
G30.9
ICD-10 Finland
Alzheimer disease, unspecified
0.2
9.2
8
424
TGA30
NOMESCO Finland
Thoracocentesis
8.0
8.9
19
24
351
Kela drug reimbursment
Apixaban, dabigatran, edoxaban and rivaroxaban for the treatment of atrial fibrillation
0.4
8.8
50
1126
OAB44, ,
SPAT
0.1
8.7
*
276
J01FA06
ATC
roxithromycin; oral
1.5
8.7
340
2523
SPAT1053
SPAT
Memory test
0.4
8.6
58
1221
D19
ICPC
Teeth/gum symptom/complaint
0.4
8.6
47
1073
H02
ICPC
Hearing complaint
0.4
8.6
34
894
SPAT1325
SPAT
Vaccination
0.6
8.5
143
2248
WF099
NOMESCO Finland
Other radiotherapy
27.8
8.5
11
*
SDA01
NOMESCO Finland
Periodontal treatment, very brief
0.4
8.5
50
1108
L17
ICPC
Foot/toe symptom/complaint
0.5
8.5
85
1554
SPAT1312
SPAT
General health counselling
0.5
8.4
89
1602
GCA32
NOMESCO Finland
Endoscopic insertion of stent into bronch
90.8
8.4
9
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
90.8
8.4
9
*
307
Kela drug reimbursment
Tacrine, donepezil, rivastigmine, galantamine and other major and expensive drugs used to treat Alzheimer's disease
0.2
8.4
13
575
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
0.3
8.4
17
637
HA1AA
NOMESCO Finland
X-ray mammography
4.0
8.4
23
58
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
8.3
8
*
1624B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Middle lobe, bronchus or lung[NEOPL MAL LOBI MEDII PULMONIS,CA MICROCELLURE]
+∞
8.3
8
*
C79.39
ICD-10 Finland
Secondary malignant tumor of the meninges, ventricle or other part of the brain
+∞
8.3
8
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
8.3
8
*
C34.92
ICD-10 Finland
Malignant tumor in unspecified localization in bronchial and pulmonary adenocarcinoma
+∞
8.3
8
*
GD004
NOMESCO Finland
Palliative radiotherapy of trachea, bronchi and lungs
+∞
8.3
8
*
1623X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Upper lobe, bronchus or lung[NEOPL MAL LOB SUPER PULMONIS,EI HIST/SYTOL DG]
+∞
8.3
8
*
SPAT1256
SPAT
Intramuscular and subcutaneous injection
0.6
8.3
169
2532
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
0.5
8.3
105
1789
D82
ICPC
Teeth/gum disease
0.5
8.3
82
1507
L15
ICPC
Knee symptom/complaint
0.4
8.2
56
1171
WX302
NOMESCO Finland
Thoracal epidural anesthesy
4.1
8.1
22
55
A07AA02
ATC
nystatin; oral
2.4
8.1
57
250
F00.10*G30.1
ICD-10 Finland
Primary degenerative dementia of the Alzheimer's type, senile onset without additional symptoms
0.1
8.1
*
304
KCD02
NOMESCO Finland
Transurethral resection of bladder
10.1
8.0
15
15
G30.8
ICD-10 Finland
Other Alzheimer disease
0.1
8.0
*
257
M17.1
ICD-10 Finland
Other primary gonarthrosis
0.5
8.0
67
1304
G04BD12
ATC
mirabegron; oral
0.3
8.0
18
635
R4110, ,
SPAT
0.2
8.0
8
386
Z76.0
ICD-10 Finland
Issue of repeat prescription
0.4
8.0
43
988
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
0.5
7.9
92
1608
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
2.4
7.9
55
240
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.6
7.7
124
1977
TQW40, ,
SPAT
0.1
7.7
*
247
S18
ICPC
Laceration/cut
0.6
7.6
184
2655
B02AA02
ATC
tranexamic acid; systemic
1.9
7.6
90
484
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
0.4
7.6
33
832
K03.64
ICD-10 Finland
Dental calculus supragingival
0.5
7.5
52
1086
G04CA01
ATC
alfuzosin; oral
0.5
7.5
57
1147
GDC00
NOMESCO Finland
Lobectomy of lung
80.7
7.4
8
*
I50.0
ICD-10 Finland
Congestive heart failure
0.4
7.4
41
932
C09CA01
ATC
losartan; oral
0.6
7.3
106
1744
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
0.6
7.3
187
2669
UGC02
NOMESCO Finland
Rigid bronchoscopy
+∞
7.3
7
*
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
+∞
7.3
7
*
C50.99
ICD-10 Finland
Breast, unspecified
+∞
7.3
7
*
WB111
NOMESCO Finland
Multiple neoadjuvant cytostatic therapy
+∞
7.3
7
*
C38.3
ICD-10 Finland
Malignant neoplasm: Mediastinum, part unspecified
+∞
7.3
7
*
C78.1
ICD-10 Finland
Secondary malignant neoplasm of mediastinum
+∞
7.3
7
*
OAB73
NOMESCO Finland
Prevention and treatment of malnutrition
15.9
7.2
11
7
I63.9
ICD-10 Finland
Cerebral infarction, unspecified
0.5
7.2
63
1211
2391A
ICD-9 Finland
Neoplasm of unspecified nature, Respiratory system
7.4
7.2
16
22
N05AX08
ATC
risperidone; systemic
0.3
7.1
26
710
B01AF02
ATC
apixaban; oral
0.4
7.1
36
849
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.1
7.1
64
312
KMAK, ,
NOMESCO Finland
0.6
7.0
167
2423
H91.1
ICD-10 Finland
Presbycusis
0.2
6.9
13
510
H13
ICPC
Plugged feeling ear
0.5
6.9
67
1246
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
0.6
6.9
192
2698
TDA90, ,
SPAT
0.1
6.9
*
275
L12
ICPC
Hand/finger symptom/complaint
0.4
6.9
26
700
Z71.8
ICD-10 Finland
Other specified counselling
0.5
6.9
73
1317
I50.9
ICD-10 Finland
Heart failure, unspecified
0.6
6.9
109
1751
DAX08
NOMESCO Finland
Fitting of hearing aid
0.2
6.9
9
369
JN6AD
NOMESCO Finland
CT of torso and neck
9.4
6.8
13
14
K86
ICPC
Hypertension uncomplicated
0.4
6.8
32
779
SCA01
NOMESCO Finland
Preventive oral health care, short
0.5
6.8
56
1097
EB4VA, ,
NOMESCO Finland
0.1
6.8
*
269
SPAT1043
SPAT
Audiometry
0.3
6.7
20
604
C10AX09
ATC
ezetimibe; oral
0.4
6.7
42
909
SPAT1310
SPAT
Counselling related to known health issue
0.6
6.6
113
1784
L82
ICD-10 Finland
Seborrhoeic keratosis
0.4
6.6
37
838
OAB43, ,
SPAT
0.2
6.5
8
340
L02BG04
ATC
letrozole; oral
70.3
6.4
7
*
J70.0
ICD-10 Finland
Acute pulmonary manifestations due to radiation
70.3
6.4
7
*
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
0.5
6.4
77
1340
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.0
6.4
68
352
HAB40
NOMESCO Finland
Wedge excision of mammary gland
14.4
6.4
10
7
C09CA06
ATC
candesartan; oral
0.5
6.4
69
1238
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
8.2
6.3
13
16
L28
ICPC
Limited function/disability (L)
0.5
6.3
73
1286
N02AX02
ATC
tramadol; systemic, rectal
1.4
6.3
354
2780
M01AX05
ATC
glucosamine; oral
0.5
6.3
72
1272
PJD41
NOMESCO Finland
Excision of cervical lymph nodes
9.3
6.3
12
13
WX290
NOMESCO Finland
Other blockage of nerve
0.6
6.3
114
1773
WPB10
NOMESCO Finland
Making a convalescent care decision
18.1
6.3
9
5
F01.9
ICD-10 Finland
Vascular dementia, unspecified
0.1
6.3
*
188
L13
ICPC
Hip symptom/complaint
0.5
6.3
49
979
1629X
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,EI HIST/SYTOL DG]
+∞
6.3
6
*
C50
ICD-10 Finland
Malignant neoplasm of breast
+∞
6.3
6
*
C34.31
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma
+∞
6.3
6
*
1629B
ICD-9 Finland
Malignant neoplasm of trachea, bronchus and lung, Bronchus and lung, unspecified[NEOPL MAL PULMONIS LOCO ALIO/NUD,CA MICROCELLURE]
+∞
6.3
6
*
C34.14
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary macrocellular anaplastic carcinoma
+∞
6.3
6
*
C78.2
ICD-10 Finland
Secondary malignant neoplasm of pleura
+∞
6.3
6
*
C34.01
ICD-10 Finland
Malignant tumor of the main bronchial epidermoid carcinoma
+∞
6.3
6
*
C32.0
ICD-10 Finland
Malignant neoplasm: Glottis
+∞
6.3
6
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
6.3
6
*
C38.4
ICD-10 Finland
Malignant neoplasm: Pleura
+∞
6.3
6
*
C79.0
ICD-10 Finland
Secondary malignant neoplasm of kidney and renal pelvis
+∞
6.3
6
*
WZC30, ,
SPAT
0.2
6.3
*
258
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.6
6.2
142
925
SAD01
NOMESCO Finland
Assessment of need for oral health care, standard
0.3
6.2
14
491
E87.6
ICD-10 Finland
Hypokalaemia
2.6
6.2
34
133
N05CF01
ATC
zopiclone; oral
1.4
6.1
314
2423
Z96.1
ICD-10 Finland
Presence of intraocular lens
0.5
6.1
66
1188
E0000UV, ,
ATC
0.6
6.1
166
2353
C09AA05
ATC
ramipril; oral
0.6
6.0
159
2272
A06AD11
ATC
lactulose; oral
1.5
6.0
183
1274
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
173
57
36.45
269.74
1.1
1.1
—
—
—
0
0
207
320
7.89
133.16
2.1
1.4
32.96
2.88
ug/l
1.97
190
243
129
124
11.79
119.77
1.2
1.5
—
—
—
0
0
81
63
13.90
85.40
1.2
1.2
—
—
—
0
0
281
938
3.77
71.10
4.2
2.2
0.77
0.83
mmol/l
11.04
271
841
122
226
6.01
64.28
1.9
2.8
—
—
—
0
0
361
5822
0.41
40.02
5.8
6.5
42.26
41.36
mmol/mol
0.90
312
5294
391
6074
0.42
38.91
3.9
5.4
2.56
2.53
mmol/l
0.24
340
5482
375
5896
0.42
37.88
3.6
4.8
4.39
4.37
mmol/l
0.14
329
5353
369
5823
0.42
37.30
3.6
4.8
1.31
1.40
mmol/l
4.21
319
5239
395
6049
0.43
36.62
4.2
5.0
6.34
6.14
mmol/l
1.69
342
5382
367
5635
0.45
31.57
3.4
4.3
1.42
1.26
mmol/l
3.30
319
5023
361
5560
0.45
31.03
3.8
4.3
1.85
2.29
mu/l
1.19
313
4911
480
6664
0.46
30.85
38.2
21.5
124.87
134.55
g/l
36.48
471
6465
480
6662
0.46
30.77
37.9
21.4
4.13
4.43
e12/l
29.97
463
6343
480
6661
0.47
30.74
38.0
21.4
254.68
235.59
e9/l
6.16
465
6380
480
6660
0.47
30.70
38.2
21.5
37.40
39.68
%
15.32
436
6010
481
6663
0.47
30.49
37.9
21.4
7.97
6.97
e9/l
11.57
464
6349
30
25
12.34
29.98
1.2
1.3
—
—
—
0
0
481
6537
0.49
26.24
30.6
18.3
4.02
4.02
mmol/l
0.15
468
6282
481
6526
0.50
25.89
30.7
18.2
137.19
139.75
mmol/l
27.98
469
6283
36
1577
0.20
24.25
1.3
1.7
1.79
1.33
mmol/l
0.69
31
1287
473
6397
0.51
24.16
16.6
9.0
28.69
25.02
u/l
2.24
461
6036
271
4389
0.48
23.67
3.3
3.5
15.40
15.06
pmol/l
1.12
234
3854
181
3363
0.44
22.70
3.6
3.9
1.84
2.30
ug/l
2.14
155
2950
400
5614
0.52
21.58
27.1
13.9
80.33
71.78
ml/min/173m2
11.50
351
4530
134
2742
0.41
20.99
3.6
3.9
21.80
24.43
%
0.91
57
1353
352
5034
0.54
18.95
33.8
17.0
15.13
15.47
%
0.98
346
4884
440
3009
1.82
18.62
9.2
3.6
10.88
12.74
umol/l
1.94
430
2800
166
3013
0.46
18.46
1.8
2.1
88.84
91.56
pmol/l
0.27
85
1588
41
90
4.71
17.64
1.3
1.5
4133.19
1291.73
e6/l
1.38
36
66
27
45
6.14
15.64
1.1
1.2
12.00
8.85
u/l
0.82
27
40
37
83
4.59
15.51
1.3
1.6
26977.93
37564.06
e6/l
0.18
30
50
85
1869
0.40
14.87
2.6
2.8
0.73
0.78
ug/l
0.21
58
1322
26
45
5.90
14.51
1.2
1.7
260.05
273.21
mosm/kgh2o
1.31
20
28
481
6077
0.60
13.95
28.3
14.9
31.57
27.16
mg/l
2.38
460
4832
134
2412
0.49
13.59
1.7
2.1
71.76
78.08
nmol/l
1.75
112
2051
434
3157
1.66
13.40
14.1
5.5
4.74
4.55
e9/l
0.69
396
2689
192
2988
0.56
11.78
4.7
4.9
0.00
0.00
estimate
-0.00
56
502
89
1762
0.46
11.53
1.5
1.6
18.09
19.91
nmol/l
0.52
80
1473
125
2172
0.52
10.96
3.1
3.1
7.14
7.60
mmol/l
0.70
96
1786
197
2998
0.57
10.93
3.6
3.7
0.00
0.01
estimate
0.69
58
557
135
2282
0.53
10.81
3.7
3.8
18.68
9.00
mg/mmol
0.58
84
1467
26
61
4.35
10.35
1.5
1.6
78.76
29.30
u/ml
0.87
20
52
150
2420
0.55
10.13
2.7
2.6
268.47
148.71
ug/l
3.59
137
2169
204
3027
0.59
10.07
3.6
3.7
0.00
0.00
estimate
-0.00
55
492
368
2718
1.56
9.85
5.4
5.3
20.34
25.40
%
13.66
363
2488
176
2694
0.58
9.72
2.3
2.3
—
—
—
0
0
18
19
9.62
9.29
2.2
1.9
—
—
—
0
0
120
675
1.88
8.83
2.7
2.4
363.66
239.53
u/l
4.00
115
621
355
2690
1.49
8.06
5.2
5.1
62.73
59.14
%
4.68
349
2462
381
2951
1.47
7.65
7.1
4.9
1.21
1.21
mmol/l
0.26
370
2609
411
3234
1.46
7.59
7.6
5.2
1.21
1.21
mmol/l
0.37
346
2725
353
2708
1.47
7.39
6.0
3.6
32.05
34.82
g/l
13.85
330
2436
34
123
2.83
7.12
1.7
1.8
38.59
55.65
u/ml
0.16
29
92
273
2023
1.48
6.70
5.5
2.0
2.37
2.34
mmol/l
3.63
249
1647
162
2347
0.63
6.66
3.9
3.9
—
—
—
0
0
83
471
1.83
5.96
3.8
3.4
2.75
1.97
mmol/l
0.68
67
343
86
496
1.80
5.86
4.0
3.5
5.36
5.19
kpa
0.85
80
461
77
430
1.86
5.82
1.5
1.6
—
—
—
0
0
372
4516
0.72
5.77
4.0
4.0
23.21
13.63
mm/h
15.05
345
4073
122
1825
0.62
5.66
2.4
2.2
3.35
2.99
mg/l
0.95
108
1511
108
1661
0.61
5.63
1.6
1.8
1135.63
1142.66
nmol/l
0.03
84
1243
105
1624
0.61
5.60
1.6
1.7
415.47
7746349.81
pmol/l
0.78
86
1291
176
1237
1.51
5.50
5.8
2.2
2.54
2.44
mmol/l
15.46
160
1033
169
1183
1.52
5.38
1.8
1.8
—
—
—
0
0
91
1433
0.60
5.20
4.1
4.0
1.01
1.02
kg/l
0.88
19
225
21
77
2.76
4.37
3.4
3.4
—
—
—
0
0
47
845
0.53
4.35
1.2
1.3
15.00
13.77
u/ml
0.05
14
281
190
2482
0.71
4.29
2.6
3.1
1648.14
1994.49
ng/l
0.25
174
2131
19
67
2.87
4.24
1.4
1.2
—
—
—
0
0
22
86
2.59
4.07
1.2
1.4
—
—
—
0
0
15
402
0.36
4.00
1.3
1.4
—
—
—
0
0
126
1751
0.68
4.00
2.8
2.5
3536.13
8333.46
umol/l
0.76
106
1457
52
883
0.57
3.95
1.2
1.3
128.71
40.02
iu/ml
0.85
16
273
27
119
2.30
3.90
1.3
1.3
—
—
—
0
0
170
2208
0.72
3.63
2.1
2.2
215.57
266.99
u/l
0.39
155
2033
28
131
2.17
3.54
1.3
1.3
—
—
—
0
0
57
907
0.61
3.39
10.6
7.8
—
—
—
0
0
20
84
2.41
3.24
1.4
1.2
—
—
—
0
0
13
45
2.91
3.03
1.2
1.1
—
—
—
0
0
13
45
2.91
3.03
1.2
1.1
—
—
—
0
0
13
45
2.91
3.03
1.2
1.1
—
—
—
0
0
18
75
2.43
2.98
1.3
1.2
—
—
—
0
0
32
172
1.89
2.84
1.3
1.6
—
—
—
0
0
56
850
0.64
2.74
3.8
5.0
31.10
32.88
%
0.52
42
564
127
1655
0.73
2.72
3.7
3.9
0.00
0.01
estimate
0.50
46
474
72
1035
0.67
2.71
1.1
1.2
0.88
1.63
u/ml
1.19
14
264
83
582
1.46
2.67
1.7
1.6
65.30
66.63
g/l
0.92
75
508
16
67
2.41
2.64
2.3
2.3
—
—
—
0
0
6
12
5.02
2.40
1.7
1.4
1967.00
53.00
nmol/24h
—
6
12
6
12
5.02
2.40
1.2
1.1
—
—
—
0
0
6
12
5.02
2.40
1.2
1.1
—
—
—
0
0
6
12
5.02
2.40
1.2
1.1
—
—
—
0
0
303
3483
0.81
2.34
4.8
2.9
113.08
50.60
u/l
4.74
277
3131
17
78
2.20
2.32
1.3
1.3
—
—
—
0
0
113
864
1.35
2.24
3.7
4.1
1.06
1.02
mmol/l
0.49
105
765
18
86
2.11
2.23
2.2
1.6
88.29
89.32
%
0.32
18
86
19
93
2.06
2.22
4.9
2.8
59.74
60.22
%
0.03
19
93
10
35
2.88
2.21
1.2
1.4
—
—
—
0
0
6
167
0.36
2.15
1.0
1.5
—
—
—
0
0
11
252
0.43
2.15
2.1
1.8
—
—
—
0
0
14
62
2.28
2.08
1.4
1.5
—
—
—
0
0
108
831
1.34
2.06
5.8
6.2
1.73
1.33
mmol/l
0.39
85
635
109
841
1.33
2.05
1.8
1.8
—
—
—
0
0
17
83
2.07
2.02
1.3
1.2
—
—
—
0
0
17
83
2.07
2.02
1.3
1.2
—
—
—
0
0
9
32
2.83
2.00
1.4
1.3
—
—
—
0
0
31
186
1.69
1.99
1.4
1.4
—
—
—
0
0
31
186
1.69
1.99
1.4
1.4
—
—
—
0
0
107
827
1.33
1.99
5.7
6.2
5.09
5.08
kpa
0.04
97
786
107
827
1.33
1.99
5.7
6.2
9.96
11.07
kpa
2.17
97
785
56
791
0.69
1.97
2.3
2.5
4.25
7.04
ug/l
2.36
49
671
18
91
2.00
1.96
3.6
2.5
5.67
4.82
e9/l
0.55
18
91
14
64
2.20
1.95
1.4
1.2
—
—
—
0
0
17
319
0.52
1.92
1.3
1.4
—
69.80
—
0
16
16
78
2.07
1.91
1.1
1.3
—
—
—
0
0
26
151
1.74
1.88
2.6
2.4
14.81
16.31
%
—
7
78
385
3455
1.19
1.86
12.2
20.0
1.22
1.45
inr
5.70
101
961
43
286
1.53
1.85
1.8
1.8
—
—
—
0
0
7
23
3.06
1.80
1.6
1.3
—
—
—
0
0
204
1731
1.22
1.79
5.4
2.5
47.75
34.80
u/l
0.73
189
1625
6
152
0.39
1.77
1.0
1.5
—
—
—
0
0
7
24
2.93
1.72
1.6
1.3
—
—
—
0
0
11
48
2.31
1.71
1.2
1.2
—
—
—
0
0
106
839
1.29
1.69
1.8
1.8
—
—
—
0
0
378
4160
0.85
1.66
3.8
4.4
8.38
3587.15
e6/l
—
8
94
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
7
25
2.81
1.65
1.1
1.1
—
—
—
0
0
39
264
1.50
1.58
1.6
1.7
—
—
—
0
0
11
50
2.21
1.57
1.4
1.4
—
—
—
0
0
7
27
2.60
1.51
1.3
1.4
—
—
—
0
0
7
27
2.60
1.51
1.0
1.1
46.86
29.53
u/l
—
7
22
27
414
0.64
1.48
2.4
2.6
0.43
0.38
e6/l
0.09
27
407
11
52
2.13
1.44
1.2
1.2
—
—
—
0
0
259
2897
0.86
1.35
3.8
4.3
26.87
148.15
ng/l
1.25
220
2238
78
620
1.28
1.25
2.8
2.2
14.07
9.54
umol/l
0.79
64
537
6
25
2.41
1.24
1.2
1.4
—
—
—
0
0
23
349
0.65
1.23
1.3
2.1
11.82
15.06
nmol/l
1.24
17
302
8
38
2.11
1.18
1.6
2.3
—
—
—
0
0
0
34
0.00
1.16
0.0
1.3
—
167.17
—
0
34
5
21
2.39
1.09
1.8
2.2
455.80
1238.43
u/ml
—
5
21
9
164
0.54
1.09
4.1
1.5
—
—
—
0
0
88
1054
0.82
1.02
2.1
2.2
11.32
12.39
umol/l
0.70
82
950
5
106
0.47
1.01
3.2
2.6
105.40
105.42
mmol/l
—
5
106
58
459
1.28
1.00
1.4
1.5
—
—
—
0
0
7
135
0.52
0.98
1.9
1.7
—
—
—
0
0
0
29
0.00
0.98
0.0
5.2
—
39.00
—
0
5
14
223
0.62
0.97
1.7
1.4
50.41
38.35
mg/l
—
9
180
413
3865
1.12
0.96
6.2
4.3
6.83
6.93
mmol/l
0.48
398
3626
12
198
0.60
0.96
1.0
1.0
—
—
—
0
0
73
598
1.24
0.95
5.3
5.0
11.85
11.92
mmol/l
0.02
65
553
27
368
0.73
0.87
4.6
3.6
54.43
47.33
%
0.88
27
362
80
945
0.83
0.83
2.2
2.3
2.20
2.23
g/l
0.21
70
857
6
32
1.88
0.82
1.5
1.1
68.22
34.90
iu/l
—
6
27
10
58
1.73
0.80
1.4
1.2
—
—
—
0
0
10
58
1.73
0.80
1.4
1.2
—
—
—
0
0
0
24
0.00
0.79
0.0
1.1
—
122.40
—
0
24
0
25
0.00
0.79
0.0
1.1
—
—
—
0
0
0
25
0.00
0.79
0.0
1.2
—
—
—
0
0
44
549
0.79
0.78
1.2
1.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
33
253
1.31
0.76
2.0
2.5
0.31
0.36
u/ml
0.49
20
154
5
24
2.09
0.74
1.0
1.4
—
—
—
0
0
9
54
1.67
0.74
1.2
1.7
—
367.43
—
0
7
17
241
0.70
0.72
1.4
1.2
133.60
100.57
iu/ml
—
5
94
11
68
1.62
0.72
1.2
1.3
18.17
8.75
u/l
0.98
11
57
5
26
1.93
0.70
2.6
2.2
—
—
—
0
0
5
26
1.93
0.70
2.6
2.2
—
—
—
0
0
24
179
1.35
0.67
2.1
2.2
107.09
133.25
g/l
1.52
11
134
5
91
0.55
0.67
1.4
1.3
—
—
—
0
0
59
497
1.20
0.64
2.2
2.2
38.29
32.75
u/l
0.32
51
399
5
29
1.73
0.64
1.0
1.1
—
—
—
0
0
130
1439
0.89
0.60
3.5
4.3
151.36
633.17
ng/l
1.93
110
1242
41
497
0.82
0.59
3.3
3.4
99.69
93.16
ng/l
0.13
35
420
110
1226
0.88
0.57
1.5
1.6
1.66
1.39
mg/l
0.69
90
954
22
284
0.77
0.55
1.5
1.4
—
—
—
0
0
78
886
0.87
0.55
2.3
2.4
20.94
22.26
%
0.36
69
738
51
433
1.19
0.53
2.1
1.7
—
—
—
0
0
26
206
1.27
0.51
1.2
1.2
—
—
—
0
0
27
215
1.26
0.51
1.1
1.9
33.01
38.70
u/l
0.82
21
176
10
67
1.50
0.49
1.0
1.4
102.80
279.09
pmol/l
—
5
56
13
94
1.39
0.46
1.7
1.8
3.20
5.68
iu/l
—
7
37
5
31
1.62
0.43
1.8
4.0
—
—
—
0
0
189
1773
1.08
0.42
2.7
2.9
0.91
0.45
e6/l
1.49
147
1356
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
204
1922
1.08
0.41
2.6
2.2
65.56
61.16
u/l
0.28
180
1753
0
17
0.00
0.40
0.0
1.1
—
15.32
—
0
9
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
0
19
0.00
0.39
0.0
1.1
—
1.12
—
0
5
0
19
0.00
0.39
0.0
1.1
—
10.04
—
0
19
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
9
66
1.37
0.38
1.4
1.3
—
—
—
0
0
23
279
0.82
0.37
4.0
4.1
1.92
1.52
mmol/l
0.68
23
273
8
113
0.71
0.37
1.4
1.6
—
—
—
0
0
5
76
0.66
0.36
1.2
1.4
—
—
—
0
0
9
124
0.72
0.35
1.1
1.2
—
—
—
0
0
6
45
1.34
0.33
1.2
1.3
434.53
68.11
pmol/l
—
6
45
69
759
0.90
0.33
2.3
3.2
212.73
300.54
ng/l
1.01
63
706
44
497
0.88
0.33
2.2
1.7
1.80
1.65
%
0.35
33
403
28
238
1.18
0.32
4.9
3.0
4.05
4.37
pmol/l
0.69
23
198
43
482
0.89
0.29
4.0
2.2
53.41
60.56
ml/min/173m2
0.57
17
195
7
57
1.23
0.29
1.3
1.2
—
—
—
0
0
253
2628
0.95
0.28
2.4
2.3
—
—
—
0
0
230
2387
0.95
0.25
3.0
3.0
—
—
—
0
0
108
1018
1.07
0.24
2.4
2.9
3.19
1.82
e6/l
0.50
53
581
6
81
0.74
0.24
1.0
1.0
—
—
—
0
0
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
5
39
1.28
0.23
1.2
1.1
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
5
40
1.25
0.22
1.2
1.1
—
—
—
0
0
5
42
1.19
0.21
1.0
1.2
—
—
—
0
0
0
11
0.00
0.21
0.0
1.3
—
126.91
—
0
11
0
11
0.00
0.21
0.0
1.6
—
—
—
0
0
0
11
0.00
0.21
0.0
1.4
—
0.64
—
0
6
15
177
0.85
0.21
1.3
1.6
—
—
—
0
0
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.1
—
1988.50
—
0
14
0
14
0.00
0.20
0.0
2.6
—
0.21
—
0
14
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
6
52
1.15
0.19
1.2
1.2
1.26
1.51
nmol/l
—
6
45
7
58
1.21
0.18
1.1
1.2
—
—
—
0
0
19
216
0.88
0.17
1.9
3.2
0.79
0.81
nmol/l
0.07
13
170
17
150
1.14
0.14
1.4
1.4
295.45
299.22
ug/g
0.02
11
92
142
1374
1.04
0.14
2.2
2.1
—
—
—
0
0
9
106
0.85
0.13
1.3
1.2
—
—
—
0
0
205
2003
1.03
0.12
2.8
3.0
58.45
97.99
e6/l
0.44
161
1563
5
46
1.09
0.09
1.0
1.0
—
—
—
0
0
5
46
1.09
0.09
1.2
1.0
—
—
—
0
0
6
55
1.09
0.09
1.3
1.2
—
—
—
0
0
6
56
1.07
0.08
1.3
1.2
—
—
—
0
0
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
6
57
1.05
0.08
1.3
1.8
255.33
287.54
mu/l
—
6
52
6
57
1.05
0.08
1.2
1.2
—
—
—
0
0
10
113
0.88
0.08
1.3
1.3
—
—
—
0
0
5
61
0.82
0.08
1.0
1.0
—
—
—
0
0
7
68
1.03
0.08
1.0
1.1
—
—
—
0
0
8
95
0.84
0.06
1.1
1.1
—
—
—
0
0
462
4649
0.99
0.05
13.3
5.0
104.23
77.06
u/l
10.39
454
4229
11
100
1.10
0.05
1.3
1.3
—
—
—
0
0
73
714
1.02
0.04
4.9
3.1
—
—
—
0
0
51
498
1.03
0.03
6.7
6.9
25.56
24.38
mmol/l
1.06
45
480
15
159
0.94
0.03
1.2
1.2
578.20
509.55
mg/l
0.31
15
150
21
201
1.05
0.03
2.6
2.1
388.76
80.95
ug/min
—
10
114
20
209
0.96
0.03
1.3
1.3
—
—
—
0
0
16
168
0.95
0.02
1.3
1.1
—
—
—
0
0
16
167
0.96
0.01
1.3
1.1
—
—
—
0
0
139
1399
0.99
0.01
2.5
2.3
7.86
4.44
e6/l
1.99
129
1248
71
703
1.01
0.01
3.1
3.0
2.01
2.06
mmol/l
0.03
56
568
107
1064
1.01
0.00
2.3
2.7
0.80
1.16
e6/l
1.02
51
627
11
114
0.96
0.00
1.3
1.6
—
—
—
0
0
11
109
1.01
0.00
1.2
1.1
—
—
—
0
0
14
145
0.97
0.00
1.1
1.2
16.80
3.63
u/ml
—
6
24
(40770918) von Willebrand factor (vWf).activity actual/normal in Platelet poor plasma by Immunoassay
0
8
0.00
-0.00
0.0
3.3
—
178.50
—
0
8
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.5
—
11.67
—
0
6
0
6
0.00
-0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
3.2
—
173.00
—
0
6
6
60
1.00
-0.00
1.0
1.2
—
—
—
0
0
5
57
0.88
-0.00
1.2
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
58
0.86
-0.00
1.2
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
7
73
0.96
-0.00
1.6
1.2
0.50
0.64
nmol/l
—
7
66
0
7
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.0
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.0
—
—
—
0
0
0
9
0.00
-0.00
0.0
1.3
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_SCLC – Small cell lung cancer
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).